Resumen

REINA, Rosa. Dexamethasone Treatment for Covid-19 Pneumonía. Rev. argent. salud pública [online]. 2021, vol.13, suppl.1, pp.1-1. ISSN 1852-8724.

Dexamethasone is currently one of the few treatments that has been shown to be effective in patients with modérate or severe SARS- CoV-2 pneumonia. A dose of 6 mg/day of dexamethasone base for 10 days has been shown to significantly reduce mortality in these patients. In Argentina, there are several commercial presentations of dexamethasone (dexamethasone sodium phosphate and dexamethasone phosphate acid). Therefore, it is important to know their equivalence in relation to dexamethasone base, in order to ensure the administration of 6 mg/day, that has been shown to decrease mortality.

Palabras clave : Dexamethasone; Respiratory Failure; COVID-19; Mortality; Argentina.

        · resumen en Español     · texto en Español     · Español ( pdf )